IDEAYA Biosciences Analyst Ratings
BenzingaMar 21 12:14 ET
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), IDEAYA Biosciences (IDYA) and Vor Biopharma (VOR)
TipRanksMar 21 06:20 ET
Strong Buy Rating for IDEAYA Biosciences Based on Strategic Partnership and Promising Oncology Pipeline
TipRanksMar 13 11:15 ET
IDEAYA Biosciences Analyst Ratings
BenzingaMar 8 09:13 ET
Analysts Are Bullish on These Healthcare Stocks: IDEAYA Biosciences (IDYA), Insulet (PODD)
TipRanksFeb 25 23:40 ET
IDEAYA Biosciences Analyst Ratings
BenzingaFeb 23 12:21 ET
Analysts Are Bullish on These Healthcare Stocks: Olema Pharmaceuticals (OLMA), IDEAYA Biosciences (IDYA)
TipRanksFeb 22 07:54 ET
IDEAYA Biosciences Analyst Ratings
BenzingaFeb 21 10:18 ET
Analysts' Top Healthcare Picks: Illumina (ILMN), IDEAYA Biosciences (IDYA)
TipRanksFeb 13 21:10 ET
IDEAYA Biosciences (IDYA) Gets a Buy From Stifel Nicolaus
TipRanksFeb 9 08:28 ET
IDEAYA Biosciences Analyst Ratings
BenzingaJan 26 09:34 ET
IDEAYA Biosciences Analyst Ratings
BenzingaJan 25 09:08 ET
Wedbush Raises Price Target on IDEAYA Biosciences to $46 From $43, Maintains Outperform Rating
MT NewswiresJan 16 11:08 ET
Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
BenzingaJan 10 12:01 ET
RBC Adjusts IDEAYA Biosciences' Price Target to $43 From $36, Keeps Outperform Rating
MT NewswiresJan 10 10:24 ET
RBC Capital Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $43
BenzingaJan 10 10:00 ET
IDEAYA Biosciences Analyst Ratings
BenzingaJan 10 09:58 ET
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), IDEAYA Biosciences (IDYA) and Surgery Partners (SGRY)
TipRanksJan 10 07:03 ET
Buy Rating Affirmed for IDEAYA Biosciences on Promising Clinical Data and Strategic Gilead Partnership
TipRanksDec 7, 2023 03:00 ET
RBC Capital Reiterates Outperform on IDEAYA Biosciences, Maintains $36 Price Target
BenzingaDec 6, 2023 10:52 ET
No Data
No Data